NDC 55545-1003-2 - Ofloxacin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 55545-1003
- Requested NDC
- 55545-1003-2
- Package NDCs from labels
- 55545-1003-2, 55545-1003-1
- Manufacturer
- FDC Limited
- Effective date
- 2017-11-21
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ofloxacin - FDC Limited | FDC Limited | 2017-11-21 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 55545-1003-1 | Ofloxacin | 5 mL in 1 BOTTLE, PLASTIC | SOLUTION | 5 | 3 | |
| 55545-1003-1 | Ofloxacin | 1 in 1 CARTON | SOLUTION | 1 | 3 | |
| 55545-1003-2 | Ofloxacin | 1 in 1 CARTON | SOLUTION | 1 | 3 | |
| 55545-1003-2 | Ofloxacin | 10 mL in 1 BOTTLE, PLASTIC | SOLUTION | 10 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 55545-1003 | OFLOXACIN SOLUTION [FDC LIMITED] | 3 | Legacy NDC, 4 package rows | 20171122_b4d09b4d-bc6a-405b-91c8-e4246336a1f7.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| OFLOXACIN | ACTIVE INGREDIENT | A4P49JAZ9H | OFLOXACIN SOLUTION [FDC LIMITED] | 2 | |
| OFLOXACIN | ACTIVE MOIETY | A4P49JAZ9H | OFLOXACIN SOLUTION [FDC LIMITED] | 2 | |
| BENZALKONIUM CHLORIDE | INACTIVE INGREDIENT | F5UM2KM3W7 | OFLOXACIN SOLUTION [FDC LIMITED] | 2 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | OFLOXACIN SOLUTION [FDC LIMITED] | 2 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | OFLOXACIN SOLUTION [FDC LIMITED] | 2 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | OFLOXACIN SOLUTION [FDC LIMITED] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Keystone | BENZALKONIUM CHLORIDE | Ecolab Inc. | 14ba88a3-af32-4191-afed-cdcc7eb8ad6a | 2024-08-05 | Warnings | F5UM2KM3W7 |
| Ecolab | BENZALKONIUM CHLORIDE | Ecolab Inc. | 02d45eff-398a-44fe-bd56-5257cf596e7d | 2024-08-05 | Warnings | F5UM2KM3W7 |
| Swisher TF | BENZALKONIUM CHLORIDE | Ecolab Inc. | d2ac8ef9-3426-4559-a8d3-6b6b5a638ef2 | 2024-08-05 | Warnings | F5UM2KM3W7 |
| ofloxacin | OFLOXACIN OTIC | NuCare Pharmaceuticals,Inc. | 1e917318-cdc7-cd2c-e063-6294a90a0cc2 | 2024-08-02 | Warnings, Adverse reactions | A4P49JAZ9H |
| Clean Force | BENZALKONIUM CHLORIDE | Ecolab Inc. | dc7bad8c-2e29-4d5d-b87e-8d9eae7c2c1c | 2024-08-02 | Warnings | F5UM2KM3W7 |
| Swisher | BENZALKONIUM CHLORIDE | Ecolab Inc. | 9f89f162-9816-4d33-aa25-0a7047725076 | 2024-08-02 | Warnings | F5UM2KM3W7 |
| Members Mark | BENZALKONIUM CHLORIDE | Ecolab Inc. | 40342279-c73d-4644-8569-2b44982149e2 | 2024-08-02 | Warnings | F5UM2KM3W7 |
| Equi-Stat | BENZALKONIUM CHLORIDE | Ecolab Inc. | 68e3174e-cb96-4739-a723-c36b2389f4f6 | 2024-08-02 | Warnings | F5UM2KM3W7 |
| AVON footworks Maximum Strength Cracked Heel | BENZALKONIUM CHLORIDE, LIDOCAINE | The Avon Company | 1f45752e-4a55-431e-e063-6294a90aa57a | 2024-08-01 | Warnings | F5UM2KM3W7 |
| WhiskCare 377 | BENZALKONIUM CHLORIDE | Whisk Products, Inc. | 2204c224-e12a-81c6-e063-6294a90a9fa4 | 2024-08-01 | Warnings | F5UM2KM3W7 |
| Facilipro | BENZALKONIUM CHLORIDE | Ecolab Inc. | 9948e401-6e5f-4d14-ad0b-f62735822c2a | 2024-08-01 | Warnings | F5UM2KM3W7 |
| PureForce | BENZALKONIUM CHLORIDE | Ecolab Inc. | e624ea46-e502-4d2d-aaa1-59954f69be05 | 2024-08-01 | Warnings | F5UM2KM3W7 |
| Ofloxacin | OFLOXACIN | Proficient Rx LP | 5a9de529-6f85-467a-97b0-8ce124c31173 | 2024-08-01 | Warnings, Adverse reactions | 312075 A4P49JAZ9H |
| Lymph/Spleen Combo | ADENOSINUM TRIPHOSPHORICUM DINATRUM, APIS MELLIFICA, CASTANEA VESCA, CEANOTHUS AMERICANUS, CHININUM ARSENICOSUM, FERRUM METALLICUM, HELIANTHUS ANNUUS, JUNIPERUS COMMUNIS, LYMPH NODE (SUIS), MYOSOTIS ARVENSIS, NATRUM MURIATICUM, NATRUM SULPHURICUM, PHYTOLACCA DECANDRA, QUERCUS GLANDIUM SPIRITUS, SPLEEN (SUIS), SUCCINUM, THYMUS (SUIS), UBIDECARENONUM | Deseret Biologicals, Inc. | afce86e2-cbfa-44d4-b803-bc2ad5053357 | 2024-07-31 | Warnings | 451W47IQ8X |
| Lymph/Spleen Combo | JUNIPERUS COMMUNIS, QUERCUS GLANDIUM SPIRITUS, MYOSOTIS ARVENSIS, NATRUM SULPHURICUM, CEANOTHUS AMERICANUS, HELIANTHUS ANNUUS, NATRUM MURIATICUM, PHYTOLACCA DECANDRA, LYMPH NODE (SUIS), SPLEEN (SUIS), THYMUS (SUIS), CHININUM ARSENICOSUM, ADENOSINUM TRIPHOSPHORICUM DINATRUM, UBIDECARENONUM, FERRUM METALLICUM, SUCCINUM, CASTANEA VESCA, APIS MELLIFICA | Deseret Biologicals, Inc. | b55787b5-5e35-4342-8f00-ef202c353877 | 2024-07-31 | Warnings | 451W47IQ8X |
| Ecolab | BENZALKONIUM CHLORIDE | Ecolab Inc. | 70516b96-5394-4f67-92c4-c50601c25946 | 2024-07-30 | Warnings | F5UM2KM3W7 |
| Keystone | BENZALKONIUM CHLORIDE | Ecolab Inc. | 6860a80e-9a5f-40e4-bec3-e7386e541f5b | 2024-07-30 | Warnings | F5UM2KM3W7 |
| Adrenapar | ARALIA QUINQUEFOLIA, AVENA SATIVA, GLANDULA SUPRARENALIS SUIS, HYPOTHALAMUS SUIS, ARSENICUM IODATUM, CALCAREA CARBONICA, IGNATIA AMARA, LYCOPODIUM CLAVATUM, NATRUM MURIATICUM, NUX VOMICA, PHOSPHORICUM ACIDUM, PHOSPHORUS, ZINCUM METALLICUM | Energique, Inc. | 4080fcfb-7ef2-45f5-8c3b-592d3b66a120 | 2024-07-29 | Warnings | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | Baxter Healthcare Corporation | f55bd888-5e01-474d-871b-24654c070178 | 2024-07-24 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium chloride | SODIUM CHLORIDE | Fresenius Kabi USA, LLC | 83994d0c-8484-4505-abb5-8a384ed12288 | 2024-07-22 | Warnings, Adverse reactions | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.